The study of quantitative structure-activity relationships (QSAR) has developed rapidly in recent years by feeding on the vast accumulation of results from medicinal chemical studies?) There are relatively few examples in the literature where the formulation of a QSAR has been followed up by the synthesis of new derivatives to check on the predictive values of the correlation equations. Some good predictions realized via QSAR are discussed by Hansch with over 20 examples.2c)
The present paper extends our earlier correlation study of antidepressant derivatives (I) , which have been discovered through random screenings, and describes the design of new , more active congeners based on the QSAR results, and the confirmation of the validity of the designs. Generally speaking, the formulation of QSAR (induction stage) should be extended to the design of more desirable compounds (deduction stage) and this should be followed by synthesis by chemists and subsequent evaluation by biologists to check on the predicted activities (proof stage). Our earlier study of 59 derivatives of I yielded Eqs . 1-4. Based on these equations we designed compounds with a strong electron-attracting group X on the 4-position in the benzene ring. These compounds were then synthesized and biologically evaluated to exhibit the very strong activities shown in Table I .
In Table II , A in the dependent variable in A/(100 -A)3) refers to the percentage inhibition of reserpine (2 mg/kg) induced ptosis in mice at a 100 mg/kg dose of the tested anilinopyrimidine, where compounds with 100% inhibition activity are estimated to be A= 99 (1) There are two types of predictions which must be considered. In the first type, one can attempt to predict the activity of new derivatives whose substituents are characterized by constants within the range of substituent space span (sss) in derivatives supporting the model equation.2d,9) Often (but not necessarily) such derivatives will have biological activities within the range already explored. After one has a reasonable distribution of data along each vector, testing of more data points in the explored substituents space is redundant. In the present case the early group of compounds (No. 1-61 in Table II) does not contain any with strong electron-attracting groups of X on the 4-position in I. This is one reason why the importance of designing the early set of compounds based on cluster analysis was proposed by Hansch.10) Eleven compound (No. 62-67 and 69-73 in Table II ) among the 17 new derivatives of I fall in this class and naturally the activities fall in the range of the 61 initial compounds.
On the other hand, the second type of prediction is that for derivatives possessing activity outside the range already explored (sss). In the present instance of the six designed compounds (No. 68 and 74-78 in Table II ) with a strong electron-withdrawing X group on the 4-position outside the sss, four are much more active than any of compounds in the initial 61 compounds, although one is moderately active and one shows weak activity. Finally, RS-2232 (No. 76 in Table II) , the most active congener was selected for preclinical investigations.11 .12) This result demonstrates that correlation equations can be used successfully to design highly active congeners.
